Epsilon M&A Deal Report - Synexus
Transaction Multiples for the Valuation of Private Companies
Private Group led by LBC / Synexus
No EMAT :
82819
Announced Date :
23/02/2015
Type :
MBO (Management Buy Out) ,SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group led by LBC
Target :
Synexus
Country :
United Kingdom
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Synexus is an international clinical trial research . > Dedicated to the recruitment and supporting pharmaceutical R&D through phase II, III & IV clinical trials at its own research centres across...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
ns | ns | ns | |
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 22/06/2015 | Eurofins Scientific | Biomnis | France | ** | 82803 |
| 27/07/2015 | Source Bioscience | Select Pharma Laboratories | Scotland | ** | 82797 |
Source: Epsilon Research / EMAT
